Cel-Sci, Sittona Co. B.V. deal

CELI purchased all rights to Sittona's Multikine technology. Multikine is a natural mixture of cytokines, human immune

Read the full 170 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE